HEALWELL AI is a healthcare technology company focused on AI and data science for preventative care.

Our mission is to improve healthcare and save lives through early identification and detection of disease. As a physician-led organization with a proven management team of experienced executives, HEALWELL AI is executing a strategy centered around developing and acquiring technology and clinical sciences capabilities that complement the company’s roadmap.

Play Video

AI-Enabled Decision Support For Healthcare Providers

Clinical Information Sources include: Clinician & EMR Access, Lab & Diagnostic Info, Clinical Research & Trials, Semi-Structured data. HEALWELL AI's Clinical Insights serve: Life Science companies, Pharmaceutical companies, Precision Medicine Companies, Medical Device Companies.
Clinical Information Sources include: Clinician & EMR Access, Lab & Diagnostic Info, Clinical Research & Trials, Semi-Structured data. HEALWELL AI's Clinical Insights serve: Life Science companies, Pharmaceutical companies, Precision Medicine Companies, Medical Device Companies.
Icons_v
Identify

Identify the gap in care and how AI can advance current standards.

Icons_v copy
Build

Build a disease specific risk screening criteria logic/code algorithm.

Icons_v copy 2
Predict

Predict and diagnose disease faster than clinicians with minimal error.

Icons_v copy 3
Train

Train clinical teams.

Icons_v copy 4
Launch

Launch primary care and/or a specialty offering segment.

Icons_v copy 6
Accelerate

Accelerate early diagnosis and linkage to care options.

Curbing Healthcare Costs, Supporting Doctors &
Improving Patient Outcomes

Patients: Early Intervention, personalized patient care, and better patient outcomes. Practitioners: Improved patient care, streamlined workflow, and decreased doctor burnout. AI Platform: Improved medical research, increased efficiency at lower cost and longer therapy durations. Pharma Companies: drug development, improved outcomes and healthier overall population.

Exclusive Strategic Partnership
& Lead Investor

Strategic Partnership between HEALWELL AI and WELL Health technologies (WELL Health AI) - TSX. WELL

#1

DIGITAL HEALTH ECOSYSTEM IN CANADA

WELL’s apps.health is Canada’s leading EMR App Ecosystem providing extensive tech enablement for care providers nationally

5M+

YEARLY PATIENT VISITS & INTERACTIONS

The largest owned and operated healthcare ecosystem in Canada and significant operations across the United States

30,000+

HEALTHCARE PROVIDERS TECH ENABLED

More than one out of every 4 doctors in Canada rely on WELL digital solutions to drive their patient services business

>$1Bn

IN M&A

Across more than 60 transactions in the clinical and digital space

Exclusive Strategic Partnership
& Lead Investor

healwell_stock_header

4M+

ANNUAL PATIENT VISITS

The largest owned & operated
healthcare ecosystem in Canada

30,000+

HEALTHCARE PROVIDERS

Enabled by WELL solutions 
across Canada and the U.S.

>$1.3Bn

IN M&A

Across more than 60 transactions

Products and Services

Khure Health

Khure Health is a wholly owned subsidiary of HEALWELL AI. Khure is an AI health technology company whose precision medicine platform harnesses clinical data, enabling physicians to rapidly screen and identify patients with rare diseases and facilitate more personalized treatment. Khure is actively working with and/or has rare and specialty disease programs in development with 6 of the top 10 Pharma
companies and international disease associations.

Pentavere

HEALWELL AI is a majority shareholder of Pentavere Research Group, a globally recognized and award-winning AI digital health company that has built a best-in-class AI engine to identify patients that are eligible for approved medications or interventions, to improve outcomes for patients and help drive
therapy growth and penetration. Over the past several years, Pentavere has published an impressive array of literature in high-impact, peer-reviewed medical journals, totalling more than 19 manuscripts, which serve as a testament to Pentavere’s capabilities and adds significant credibility to their
technology.

PolyClinic

HEALWELL AI Polyclinic provides onsite integrated health services including primary care, specialist care, lab services, and an in-house clinical research organization. With integrated systems and data-driven tools, HEALWELL AI Polyclinic plans to unlock meaningful insights from consistent, high-quality, structured clinical information from over 50 primary care physicians and specialists, labs, and clinical
trials.

WELL AI Decision Support

Developed in partnership with WELL Health Technologies Corp., HEALWELL AI provides ‘WELL AI Decision Support’, a groundbreaking solution that leverages AI technologies to enable the earlier diagnosis, treatment and improved quality of life for the patient. WELL AI Decision Support enables healthcare providers to accurately identify over 110 complex or rare diseases often overlooked by traditional methods, providing hope to thousands of patients across Canada.

Proven & Experienced Team

Dr. Alexander Dobranowski

CHIEF EXECUTIVE OFFICER

Anthony Lam

CHIEF FINANCIAL OFFICER

Adam Hutton

Co-Chief Operating Officer

Paulo Gomes

CO-CHIEF OPERATING OFFICER

Don Watts

PRESIDENT KHURE HEALTH (SUBSIDIARY)

Blake Corbet

SVP CORPORATE DEVELOPMENT

Dr. Alexander Dobranowski

CHIEF EXECUTIVE OFFICER

Scott Nirenberski

CHIEF FINANCIAL OFFICER

Adam Hutton

Co-Chief Operating Officer

Paulo Gomes

Co-Chief Operating Officer

Don Watts

PRESIDENT KHURE HEALTH (SUBSIDIARY)

Blake Corbet

SVP CORPORATE DEVELOPMENT

Board of Directors

Hamed Shahbazi

CHAIRMAN

Dr. Alexander Dobranowski

DIRECTOR & CEO

Kingsley Ward

DIRECTOR

Erik Danudjaja

DIRECTOR

Bashar Al-Rehany

DIRECTOR

Investors

Play Video

Latest News

HEALWELL AI to Acquire VeroSource Solutions and its Cloud-based Health Data Interoperability Platform to Help Large Enterprises Adopt AI-Powered Population Health Capabilities

June 6, 2024

HEALWELL AI’s Pentavere Announces Partnership with Takeda to Support Rare Disease Real-World Evidence Analysis for Patients living with Hereditary Angioedema

June 6, 2024

HEALWELL AI Appoints Anthony Lam as New Chief Financial Officer

June 4, 2024

HEALWELL AI Closes Upsized $20 Million Bought Deal Offering

May 22, 2024

HEALWELL AI’s Pentavere Partners with Sunnybrook and Successfully Demonstrates its AI Powered Clinician Co-pilot System Can Improve Cancer Staging in Prestigious Peer Reviewed Medical Journal

May 21, 2024

HEALWELL AI Participates in Leading-Edge Research on Chronic Kidney Disease Highlighting the Potential of its AI Powered Clinical Co-Pilot

May 16, 2024

HEALWELL AI Reports Q1-2024 Financial Result

May 14, 2024

HEALWELL AI to Announce Fiscal First Quarter 2024 Financial Results on May 14, 2024 

May 10, 2024

HEALWELL AI Inc. Announces Upsize of Bought Deal to Up to $20 Million

May 6, 2024

HEALWELL AI Announces $16 Million Bought Deal Private Placement

May 6, 2024

WELL Launches its Second-Generation AI powered Physician Co-pilot with Chronic Disease Detection Powered by HEALWELL AI

May 2, 2024

HEALWELL Subsidiaries, Khure Health & Pentavere Research Group, to Participate and Present at Upcoming Globally Recognized Medical Conferences

April 17, 2024

HEALWELL AI’s Pentavere Achieves Validation of Generative AI for Preventative Care Through Landmark Publication

April 4, 2024

HEALWELL AI to Participate in Upcoming Investor Conferences

April 3, 2024

HEALWELL AI Reports Q4 and Full Year 2023 Financial Results

March 28, 2024

HEALWELL AI to Announce Fourth Quarter and Year End 2023 Financial Results on March 28, 2024

March 27, 2024

HEALWELL AI’s Intrahealth Provides Update on New Customer Implementation with Toronto Public Health

March 26, 2024

HEALWELL AI Provides Corporate Update and Preliminary Financial Results for the Year Ended December 31, 2023

March 21, 2024

HEALWELL AI Announces New Commercial Agreements with WELL Health USA and Circle Medical, Bringing AI-Based Preventative Care Solutions to U.S. Market

March 14, 2024

HEALWELL AI Files Base Shelf Prospectus

February 29, 2024

WELL Health Founder & CEO Hamed Shahbazi Appointed Chairman of the Board of HEALWELL AI

February 27, 2024

HEALWELL AI’s Intrahealth Provides Update on New Customer Implementation at Canuck Place Children’s Hospice

February 15, 2024

HEALWELL AI’s Pentavere Referenced by Several Leading Global Organizations for its Strength in Artificial Intelligence for Preventative Care

February 8, 2024

HEALWELL AI Completes Acquisition of Intrahealth

February 1, 2024

HEALWELL AI to Acquire Intrahealth to Create Next Generation AI Powered EHR

January 25, 2024

HEALWELL AI Provides Corporate Update Highlighting its Growth and Value Creation Strategy and Recent Commercial Successes

January 23, 2024

HEALWELL AI to Participate in Upcoming Investor Conferences

January 8, 2024

HEALWELL AI Closes Upsized $11.5 Million Bought Deal Offering, Including Full Exercise of Over-Allotment Option

December 22, 2023

HEALWELL AI Announces Upsize in Bought Deal Offering to $10 Million

December 6, 2023

HEALWELL AI Announces $8 Million Bought Deal Public Offering

December 5, 2023

HEALWELL AI Completes Acquisition of ‘Pentavere’, a Leading Healthcare AI and Data Science Company

December 4, 2023

HEALWELL AI Announces the Commencement of Trading on OTCQX and Receives DTC Eligibility 

November 21, 2023

HEALWELL AI to Acquire Control of AI Leader ‘Pentavere’ to Help Solve Some of Healthcare’s Toughest Data Challenges

November 15, 2023

HEALWELL AI Reports Q3-2023 Financial Results

November 15, 2023

HEALWELL AI Makes Investment and Launches Strategic Alliance with ‘doctorly’ to Bring HEALWELL’s Clinical Decision Support to European Market

November 9, 2023

HEALWELL AI to Announce Third Quarter 2023 Financial Results on November 15, 2023

November 8, 2023

WELL Health Launches ‘WELL AI Decision Support’ Powered by HEALWELL AI; Empowering Healthcare Providers with Next Generation Decision Support Systems

October 17, 2023

HEALWELL AI Announces Closing of $8 Million Bought Deal Private Placement

October 17, 2023

HEALWELL AI Announces $8 Million Bought Deal Private Placement
Form 19 Exemption Offering

October 3, 2023

MCI Announces Closing of Strategic Transaction with WELL Health, Changes Name to HEALWELL AI, and Debuts as AI and Data Science Focused Healthcare Technology Business MCI Onehealth Enters into Agreements with WELL Health to Sell Clinical Assets, Raise New Financing, and Empower its AI-Focused Digital Healthcare Business

October 2, 2023

Please visit Sedar+ for complete filings and news releases prior to October 2023